SIS3 HCl - 10mM in DMSO , CAS No.521984-48-5

CAS: 521984-48-5 Cat. No.: S408294 Formula: C28H27N3O3•HCl Molecular Weight: 489.99 PubChem CID: 16079005
AVAILABLE TO ORDER
GRADE & PURITY 10mM in DMSO
Synonyms
2-​Propen-​1-​one, 1-​(3,​4-​dihydro-​6,​7-​dimethoxy-​2(1H)​-​isoquinolinyl)​-​3-​(1-​methyl-​2-​phenyl-​1H-​pyrrolo[2,​3-​b]​pyridin-​3-​yl)​-​, hydrochloride (1:1)​, (2E)​-
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Size
USA
Germany (EU)*
Price
Qty
1ml
S408294-1ml
1 In stock
—

$199.90

$291.90
Save $92.00 (31.52%)
Enter a quantity for the sizes you want to add.
🧪
Why this grade

10mM in DMSO for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -80°C Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 1 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

Information

SIS3 HCl SIS3, a novel specific inhibitor of Smad3 , inhibits TGF-β and activin signaling by suppressing Smad3 phosphorylation without affecting the MAPK/p38, ERK, or PI3-kinase signaling pathways.
In vitro

Addition of SIS3 attenuates the effects of TGF-β1 by reducing the transcriptional activity. SIS3 also inhibits the myofibroblast differentiation of fibroblasts by TGF-β1. SIS3 completely diminishes the constitutive phosphorylation of Smad3 as well as the up-regulated type I collagen expression in scleroderma fibroblasts, thus abolishes the ECM overexpression in the TGF-β1-treated normal dermal fibroblasts and scleroderma fibroblasts in vitro.

In vivo

SIS3 inhibits Smad3 activation in streptozotocin(STZ)-induced diabetic nephropathy in Tie2-Cre;Loxp-EGFP mice. It also reduces AGE-induced EndoMT and decreases EndoMT in STZ-induced diabetic nephropathy in Tie2-Cre;Loxp-EGFP mice. SIS3 significantly reduces collagen IV and fibronectin expression in the glomeruli and tubulointerstitium of STZ-injected Tie2-Cre;Loxp-EGFP mice, suggesting that SIS3 retards the early development of STZ-induced diabetic glomerulosclerosis and tubulointerstitial fibrosis. However, SIS3 administration does not reduce proteinuria.
Cell Data

cell lines:

Concentrations:0.3, 1, 3 μM

Incubation Time:72 h

Powder Purity:≥97%

Specifications

Synonyms
2-​Propen-​1-​one, 1-​(3,​4-​dihydro-​6,​7-​dimethoxy-​2(1H)​-​isoquinolinyl)​-​3-​(1-​methyl-​2-​phenyl-​1H-​pyrrolo[2,​3-​b]​pyridin-​3-​yl)​-​, hydrochloride (1:1)​, (2E)​-
Specifications & Purity
10mM in DMSO
Biochemical and Physiological Mechanisms
SIS3, a novel specific inhibitor of Smad3, inhibits TGF-β and activin signaling by suppressing Smad3 phosphorylation without affecting the MAPK/p38, ERK, or PI3-kinase signaling pathways.
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
This product requires cold chain shipping. Ground and other economy services are not available.
Names and Identifiers
Isomeric SMILES CN1C(=C(C2=C1N=CC=C2)/C=C/C(=O)N3CCC4=CC(=C(C=C4C3)OC)OC)C5=CC=CC=C5.Cl
PubChem CID 16079005
Molecular Weight 489.99

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Documents & Articles
Citations of This Product
Solution Calculators
Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.